Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients.

CKD affects almost one-third of patients with symptomatic ATTRv. The role of ATTRv per se in the development of CKD in this population remains to be determined, but some patients may benefit from specific therapies.